PriceTargets.com logo

Neogen - NEOG Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $20.00
  • Forecasted Upside: 0.45%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$19.91 As of 02/7/2023 02:41 PM ET
▲ +0.02 (0.10%)

This chart shows the closing price for NEOG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Neogen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NEOG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NEOG

Analyst Price Target is $20.00
▲ +0.45% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Neogen in the last 3 months. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00. The average price target represents a 0.45% upside from the last price of $19.91.

This chart shows the closing price for NEOG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Neogen. This rating has held steady since November 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/8/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/20/2023Piper SandlerBoost Target$17.00 ➝ $20.00Low
12/14/2022Piper SandlerBoost TargetNeutral$14.00 ➝ $17.00Low
11/22/2022William BlairUpgradeMarket Perform ➝ OutperformLow
10/10/2022Piper SandlerLower TargetNeutral$20.00 ➝ $14.00Low
8/30/2022Piper SandlerLower TargetNeutral$26.00 ➝ $20.00Low
7/11/2022Piper SandlerInitiated CoverageNeutral$25.00N/A
7/23/2020Roth CapitalBoost TargetNeutral$16.75 ➝ $18.75Medium
7/21/2020William BlairReiterated RatingMarket PerformLow
7/14/2020StephensReiterated RatingBuy$22.00High
2/10/2020StephensInitiated CoverageEqual Weight ➝ Overweight$22.00High
12/31/2019Roth CapitalReiterated RatingNeutralMedium
7/24/2019Craig HallumBoost TargetBuy ➝ In-Line$18.00 ➝ $19.50High
5/23/2019GuggenheimInitiated CoverageNeutral ➝ NeutralHigh
3/19/2019Craig HallumUpgradeHold ➝ Buy$15.69Medium
12/21/2018Craig HallumReiterated RatingHold$15.00High
12/14/2018Roth CapitalReiterated RatingNeutralLow
7/18/2018Craig HallumBoost TargetHold$16.25 ➝ $17.50Medium
3/26/2018StephensReiterated RatingEqual Weight ➝ Hold$15.50 ➝ $16.25Medium
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.40 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/12/2022
  • 7 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/11/2022
  • 7 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
9/10/2022
  • 14 very positive mentions
  • 14 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
Mentions as of
10/10/2022
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2022
  • 6 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/8/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/7/2023

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Neogen logo
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Read More

Today's Range

Now: $19.91
Low: $19.62
High: $20.14

50 Day Range

MA: $17.03
Low: $14.57
High: $21.41

52 Week Range

Now: $19.91
Low: $10.49
High: $36.90

Volume

783,872 shs

Average Volume

2,745,703 shs

Market Capitalization

$4.30 billion

P/E Ratio

398.20

Dividend Yield

N/A

Beta

0.92

Frequently Asked Questions

What sell-side analysts currently cover shares of Neogen?

The following Wall Street research analysts have issued research reports on Neogen in the last twelve months: Piper Sandler, StockNews.com, and William Blair.
View the latest analyst ratings for NEOG.

What is the current price target for Neogen?

1 Wall Street analysts have set twelve-month price targets for Neogen in the last year. Their average twelve-month price target is $20.00, suggesting a possible upside of 0.6%. Piper Sandler has the highest price target set, predicting NEOG will reach $20.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $20.00 for Neogen in the next year.
View the latest price targets for NEOG.

What is the current consensus analyst rating for Neogen?

Neogen currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NEOG will outperform the market and that investors should add to their positions of Neogen.
View the latest ratings for NEOG.

What other companies compete with Neogen?

Other companies that are similar to Neogen include QuidelOrtho, Meridian Bioscience, Lantheus, Intellia Therapeutics and Celldex Therapeutics. Learn More about companies similar to Neogen.

How do I contact Neogen's investor relations team?

Neogen's physical mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company's listed phone number is (517) 372-9200 and its investor relations email address is [email protected] The official website for Neogen is www.neogen.com. Learn More about contacing Neogen investor relations.